HYLAND IMMUNO

PHARMACEUTICALS, SPECIFICALLY PHARMACEUTICALS USED IN PLASMA VOLUME, SUBSTITUTION OF PLASMA PROTEINS, RECOMBINANT PROTEIN PHARMACEUTICALS, BLOOD COAGULATION AND FIBRINOLYSIS, TISSUE ADHESION, INTRAVENOUS IMMUNO THERAPY, PASSIVE IMMUNIZATION, ACTIVE IMMUNIZATION AND SIMULATION, ACTIVE IMMUNIZATION AND SIMULTANEOUS PROPHYLAXIS